Can ovarian aging be delayed by pharmacological strategies?

Citations Over TimeTop 10% of 2019 papers

Abstract

Aging has been regarded as a treatable condition, and delaying aging could prevent some diseases. Ovarian aging, a special type of organ senescence, is the earliest-aging organ, as ovaries exhibit an accelerated rate of aging with characteristics of gradual declines in ovarian follicle quantity and quality since birth, compared to other organs. Ovarian aging is considered as the pacemaker of female body aging, which drives the aging of multiple organs of the body. Hence, anti-ovarian aging has become a research topic broadly interesting to both biomedical scientists and pharmaceutical industry. A marked progress has been made in exploration of possible anti-ovarian agents or approaches, such as calorie restriction mimetics, antioxidants, autophagy inducers etc., over the past years. This review is attempted to discuss recent advances in the area of anti-ovarian aging pharmacology and to offer new insights into our better understanding of molecular mechanisms underlying ovarian aging, which might be informative for future prevention and treatment of ovarian aging and its related diseases.

Related Papers

• → Calorie-restriction and longevity. End of a dream, at least for primates?(2013)10 cited
• → Why calorie restriction would work for human longevity(2006)36 cited
• → Growth Hormone and IGF-1 Axis in Aging and Longevity(2017)8 cited
• → Restricted calorie Intake and Autophagy: is there a link?(2018)
• → Biodemography of Aging and Longevity(2019)